All
Clinical Trial Harnesses Power of Natural Killer Cells to Treat Neuroblastoma
FOR IMMEDIATE RELEASE Clinical Trial Harnesses Power of Natural Killer Cells to Treat Neuroblastoma Nov 13, 2018 New York City— Researchers have made rapid advances in understanding how to manipulate the immune system safely to destroy cancer cells. Adoptive transfer of haploidentical natural killer (NK) cells has shown promise as a treatment option…
Transatlantic Clinical Trial For Children With Neuroblastoma is Open For Enrollment in the U.K. – Soon to Open in The U.S. and Germany
June 11, 2018 FOR IMMEDIATE RELEASE TRANSATLANTIC CLINICAL TRIAL FOR CHILDREN WITH NEUROBLASTOMA IS OPEN FOR ENROLLMENT IN THE U.K. – SOON TO OPEN IN THE U.S. AND GERMANY Charities Collaborate to Initiate International Phase 1 Clinical Trial for Children with Neuroblastoma June 1, 2018 – NEW YORK – Solving Kids’ Cancer has partnered with Band…
The Childhood Cancer STAR Act has been signed!
The Childhood Cancer Star Act of 2017 is now law, a landmark moment for the childhood cancer community. You can find a summary of the new law, signed on June 5, 2018 by President Trump, below. The passage of the STAR Act was a true community effort that involved years of patience, hard work, and…
Solving Kids’ Cancer 2018 Spring Celebration
Solving Kids’ Cancer Closer to Cures Honoring Usman “Oz” Azam, MD President & CEO Tmunity Therapeutics Thomas Gad Founder & President Y-mAbs Therapeutics with Master of Ceremonies, Mikhail “Doctor Mike” Varshavski, World’s Most Followed Doctor Hosted by Gabby & Gianpaolo, De Felice, Lindy Gad, Angelina Jolin, Jan Planit, Frederique van der Wal, and Bonnie Young…
Solving Kids’ Cancer to honor two industry leaders at 2018 Annual Spring Celebration Gala
APRIL 25, New York, NY: On Wednesday, May 16th, Solving Kids’ Cancer (SKC) will hold its annual Spring Celebration Benefit Gala. This event, SKC’s signature research fundraiser, draws industry leaders from across the nation to celebrate distinguished individuals who have contributed to the advancement of pediatric cancer therapies. The 2018 honorees are Usman “Oz”…
TWiPO #73 – Interview with Dr. Peter Adamson
Host, Dr. Timothy Cripe from Nationwide Children’s Hospital, along with his co-hosts – Dr. Ryan Roberts, Dr. Nilay Shah, Dr. Keri Streby, and Dr. Mark Ranalli, interview Dr. Peter Adamson from Children’s Hospital of Philadelphia. Dr. Adamson was previously interviewed back in 2011, in Podcast #9, and they discuss the progress that has been made since…
TWiPO #72 – Interview with Dr. Eugene Hwang
Hosts, Dr. Timothy Cripe, Dr. Keri Steby, Dr. Ryan Roberts, and Dr. Jonathan Finlay from Nationwide Children`s Hospital are joined by Dr. Eugene Hwang, who is a pediatric hematologist-oncologist at the Children`s National Medical Center in Washington D.C
TWiPO #71 – Interview with Nancy Goodman
December 21, 2017 – Host, Dr. Timothy Cripe, from Nationwide Children`s Hospital in Columbus, Ohio had the honor of interviewing Nancy Goodman, Founder and Executive Director of Kids v. Cancer in Washington DC.
A Welcome Gift
What began as a proposal for a four center US-based clinical trial of a promising combination therapy for children battling brain tumors, has expanded into a large-scale clinical trial at 58 centers in 13 countries, that brings new hope to children across the globe, who have run out of treatment options.
Podcast & Webinars
TWiPO #73 – Interview with Dr. Peter Adamson
Host, Dr. Timothy Cripe from Nationwide Children’s Hospital, along with his co-hosts – Dr. Ryan Roberts, Dr. Nilay Shah, Dr. Keri Streby, and Dr. Mark Ranalli, interview Dr. Peter Adamson from Children’s Hospital of Philadelphia. Dr. Adamson was previously interviewed back in 2011, in Podcast #9, and they discuss the progress that has been made since…
TWiPO #72 – Interview with Dr. Eugene Hwang
Hosts, Dr. Timothy Cripe, Dr. Keri Steby, Dr. Ryan Roberts, and Dr. Jonathan Finlay from Nationwide Children`s Hospital are joined by Dr. Eugene Hwang, who is a pediatric hematologist-oncologist at the Children`s National Medical Center in Washington D.C
TWiPO #71 – Interview with Nancy Goodman
December 21, 2017 – Host, Dr. Timothy Cripe, from Nationwide Children`s Hospital in Columbus, Ohio had the honor of interviewing Nancy Goodman, Founder and Executive Director of Kids v. Cancer in Washington DC.
TWiPO #70 – Interview with Dr. Joshua Rubin
Hosts, Dr. Timothy Cripe, Dr. Ryan Roberts, and Dr. Nilay Shah from Nationwide Children`s Hospital in Columbus, Ohio interview Dr. Joshua Rubin from Washington University.
TWIPO #69 – Interview with Dr. Peter Shields
November 28, 2017 – Hosts, Dr. Timothy Cripe, Dr. Nilay Shah, and Dr. Keri Steby from Nationwide Children`s Hospital in Columbus Ohio are joined by Dr. Peter Shields from Ohio State University.
TWiPO #68 – Interview with Dr. Dean Lee
Oct. 8, 2017 – Hosts Dr. Timothy Cripe and Dr. Nilay Shah, from Nationwide Children`s Hospital in Columbus, Ohio, are joined by Dr. Dean Lee to discuss their experience with T-cell CARs (Chimeric Antigen Receptors).
TWiPO #67 – Interview with Dr. Mitchell Cairo
September 29, 2017 Hosts Dr. Nilay Shah, Dr. Ryan Roberts, and Dr. Keri Streby from Nationwide Childrens Hospital in Columbus, Ohio, sit down with Dr. Mitchell Cairo to discuss his experiences within the pediatric cancer research sector.
TWiPO #65 – Interview with Dr. Brenda Weigel
In this podcast, Dr. Brenda Weigel, University of Minnesota, shares her background and why she became involved in childhood cancer research. She discusses the current challenges and where she sees research going in the future.
TWIPO #66 – Interview with Dr. Rani George
Host Dr. Ryan Roberts, from Nationwide Children`s Hospital, interviews Dr. Rani George, Dana Farber/Boston Children`s Center, about progress being made in pediatric cancer research
Press Release
Clinical Trial Harnesses Power of Natural Killer Cells to Treat Neuroblastoma
FOR IMMEDIATE RELEASE Clinical Trial Harnesses Power of Natural Killer Cells to Treat Neuroblastoma Nov 13, 2018 New York City— Researchers have made rapid advances in understanding how to manipulate the immune system safely to destroy cancer cells. Adoptive transfer of haploidentical natural killer (NK) cells has shown promise as a treatment option…
Transatlantic Clinical Trial For Children With Neuroblastoma is Open For Enrollment in the U.K. – Soon to Open in The U.S. and Germany
June 11, 2018 FOR IMMEDIATE RELEASE TRANSATLANTIC CLINICAL TRIAL FOR CHILDREN WITH NEUROBLASTOMA IS OPEN FOR ENROLLMENT IN THE U.K. – SOON TO OPEN IN THE U.S. AND GERMANY Charities Collaborate to Initiate International Phase 1 Clinical Trial for Children with Neuroblastoma June 1, 2018 – NEW YORK – Solving Kids’ Cancer has partnered with Band…
The Childhood Cancer STAR Act has been signed!
The Childhood Cancer Star Act of 2017 is now law, a landmark moment for the childhood cancer community. You can find a summary of the new law, signed on June 5, 2018 by President Trump, below. The passage of the STAR Act was a true community effort that involved years of patience, hard work, and…
Solving Kids’ Cancer 2018 Spring Celebration
Solving Kids’ Cancer Closer to Cures Honoring Usman “Oz” Azam, MD President & CEO Tmunity Therapeutics Thomas Gad Founder & President Y-mAbs Therapeutics with Master of Ceremonies, Mikhail “Doctor Mike” Varshavski, World’s Most Followed Doctor Hosted by Gabby & Gianpaolo, De Felice, Lindy Gad, Angelina Jolin, Jan Planit, Frederique van der Wal, and Bonnie Young…
Solving Kids’ Cancer to honor two industry leaders at 2018 Annual Spring Celebration Gala
APRIL 25, New York, NY: On Wednesday, May 16th, Solving Kids’ Cancer (SKC) will hold its annual Spring Celebration Benefit Gala. This event, SKC’s signature research fundraiser, draws industry leaders from across the nation to celebrate distinguished individuals who have contributed to the advancement of pediatric cancer therapies. The 2018 honorees are Usman “Oz”…
Brain Tumor Clinical Trial Now Enrolling Children
November 16, 2017 – DURHAM, NC: A Phase 1 clinical trial leveraging the re-engineered polio virus is now open for enrollment to children 12 years and older at the Preston Robert Tisch Brain Tumor Center, Duke University Medical Center. After years of following the progress of this promising therapy against adult glioblastoma and working with…
Targeted Therapy for Children with ALK-Driven Neuroblastoma
Lorlatinib may prove effective for the treatment of neuroblastoma. Solving Kids Cancer is leading an international effort of like-minded nonprofits to provide nearly $400,000 of collaborative funding for an innovative clinical trial to bring a potentially life-saving therapy to kids.
Advocacy in Action
Solving Kids` Cancer was the first charity to ever go against the UK healthcare system without a pharmaceutical company involved. As a result, the National Institute for Health and Care Excellence (NICE) recently announced that it has upheld SKC`s appeal against the Institutes decision not to recommend dinutuximab for treating high-risk neuroblastoma.
Precision Medicine Advances for Children With Neuroblastoma
November 17, 2016
Next Generation Personalized Neuroblastoma Therapy gives hope to children with relapse or refractory disease.
News & Views
A Welcome Gift
What began as a proposal for a four center US-based clinical trial of a promising combination therapy for children battling brain tumors, has expanded into a large-scale clinical trial at 58 centers in 13 countries, that brings new hope to children across the globe, who have run out of treatment options.
Lace Up for Kids
This September, Solving Kids` Cancer is raising awareness for childhood cancer awareness month by distributing free gold shoelaces as part of their #LaceUpforKids campaign.
Access to Cures Should Have No Borders
British government denies children access to proven cancer treatment for neuroblastoma. Decision will force UK families to travel abroad to access treatment
Lila May Tutu Trot
May 10, 2016
The third annual Lila May Tutu Trot but this years Tutu Trot, sadly, was missing its princess.
Chesterfield Child Is Honored By Cancer Charity
August 26, 2015
By – Allison Tretina and Martha Esposito
Videos
SKC 2015 Year-End Slideshow
This video features the various events that were hosted or attended by Solving Kids` Cancer in 2015. Happy New Year!
Kyra Kardong
June 8, 2015
Solving Kids` Cancer`s approach is to understand the research landscape, strengthen the science, cure and care for the child. The GD2 T Cell Therapy trial at Texas Children`s Hospital is helping children with neuroblastoma like Kyra Kardong.
The Promise of Immunotherapy
December 2014
Immunotherapy is changing the paradigm for children with cancer. Solving Kids` Cancer has teamed up with the same researchers who helped save Emily Whitehead`s life to bring a new treatment option for children with neuroblastoma.
Runway Heroes
November 05, 2014
Childhood cancer fighters and survivors ages 3- 13 walk the runway in Bloomingdales on 59th Street. With the help of everyone involved the event was a complete success and the children in their hand-picked outfits truly earned the title “Runway Heroes”.
Jordyn Olsen
Jordyn being diagnosed at 6 months old with neuroblastoma was a devastating shock for mother, Jodie. After 6 ineffective rounds of chemotherapy, radiation, and surgery Jodie was left without any options, which in turn lead her to an experimental clinical trial sponsored by Solving Kids Cancer. This is the story of their journey to save Jordyn.
Searching for a Solution
June 20, 2014
Our co-founders, John London and Scott Kennedy, started Solving Kids` Cancer after they each lost their children to a deadly form of pediatric cancer. Since 2007, Solving Kids` Cancer has created 15 new treatment options through clinical trials.
Nifurtimox Clinical Trial
Solving Kids` Cancer co-founder John London shares how he stumbled upon nifurtimox as a treatment option for neuroblastoma and brought it to a phase I clinical trial.
Challenging the Status Quo
Solving Kids Cancer is a nonprofit enterprise dedicated to facilitating the development of therapies to improve survivorship of the deadliest childhood cancers through an innovative and aggressively funded model.